| JKN17495
|
MG115
|
133407-86-0 |
>98% |
O=C(OCC1=CC=CC=C1)N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC)C=O)=O)=O
|
| JKN17494
|
N-(3,4-二羟基苯乙基)甲基丙烯酰胺
|
471915-89-6 |
>98% |
C=C(C)C(NCCC1=CC=C(O)C(O)=C1)=O
|
| JKN17493
|
N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide
|
129833-52-9 |
>98% |
CC1=C(C=CC=C1Br)NC(=O)C=NO
|
| JKN17492
|
N-(反式-环氧丁二酰�；；；；；；�)-L-亮氨酸-4-胍基丁基酰胺
|
66701-25-5 |
>98% |
O=C([C@@H]1[C@@H](C(O)=O)O1)N[C@H](C(NCCCCNC(N)=N)=O)CC(C)C
|
| JKN17491
|
NS75A
|
130143-01-0 |
>98% |
C[C@H](C(N)=O)NC([C@H]1N(C([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@@H](CCCNC(N)=O)NC([C@H](CC2=CC=C(O)C=C2)NC([C@H](CO)NC([C@@H](CC3=CC=CN=C3)NC([C@@H](CC4=CC=C(Cl)C=C4)NC([C@@H](CC5=CC=C6C=CC=CC6=C5)NC(C)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC1)=O.CC(O)=O.CC(O)=O
|
| JKN17490
|
OPN expression inhibitor 1
|
2257492-95-6 |
>98% |
C[C@@H]1CC[C@H]2[C@H](C(O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OCC5=CN(N=N5)CC6=CC=CC=C6)C
|
| JKN17489
|
PF-04929113
|
908115-27-5 |
>98% |
CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C
|
| JKN17488
|
PF734200
|
869490-23-3 |
>98% |
O=C(N1CC(F)(F)CC1)[C@H]2NC[C@@H](N3CCN(C4=NC=CC=N4)CC3)C2
|
| JKN17487
|
salutaridine
|
1936-18-1 |
>98% |
CN1CC[C@]23C=C(C(=O)C=C2[C@H]1CC4=C3C(=C(C=C4)OC)O)OC
|
| JKN17486
|
TNG260
|
2935964-98-8 |
>98% |
C[S@@](=N)(=O)C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=C(C=C3)F)N
|
鄂公网安备42011102005485号 